US Patent 11760763 Heteroaryl compounds useful as MK2 inhibitors
Patent 11760763 was granted and assigned to Bristol-Myers Squibb on September, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 20 Sep, 2023
Golden AI
Edits made to:
Infobox (+24 properties)
Article (+137 characters)
US Patent 11760763 Heteroaryl compounds useful as MK2 inhibitors
Article
Patent abstract
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Alexander L. Ruchelman
Jian Guo
John Malona
Sekhar S. Surapaneni
Date of Patent
September 19, 2023
Patent Application Number
17477649
Date Filed
September 17, 2021
Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11760763 Heteroaryl compounds useful as MK2 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.